BRAFV600E and NRASQ61L/Q61R mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|69|4|680-686

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.69, Iss.4, 2016-10, pp. : 680-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contiguous verrucous proliferations in syringocystadenoma papilliferum: A retrospective analysis with additional evaluation via mutation‐specific BRAFV600E immunohistochemistry

By  

JOURNAL OF CUTANEOUS PATHOLOGY, Vol. 45, Iss. 3, 2018-03 ,pp. : 212-216

John Wiley & Sons Inc

Access to resources Recommend Favorite

Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France)

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 12, 2015-12 ,pp. : 2436-2443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combining BRAFV600E inhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 9, 2015-09 ,pp. : 709-710

John Wiley & Sons Inc

Access to resources Recommend Favorite

Absence of BRAFV600E mutation in odontogenic keratocysts

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 47, Iss. 2, 2018-02 ,pp. : 186-191

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAFV600E Mutation

By  

Oncology Research and Treatment, Vol. 40, Iss. 10, 2017-09 ,pp. : 586-592

Karger

Access to resources Recommend Favorite